Ras-associated protein 1 (Rap1) signaling pathway (Rap1 pathway)

The Rap1 signaling pathway encompasses molecular mechanisms controlled by the small GTPase Rap1, a member of the Ras superfamily. Rap1 functions as a molecular switch, toggling between active (GTP-bound) and inactive (GDP-bound) states regulated by specific GEFs (guanine nucleotide exchange factors) and GAPs (GTPase-activating proteins)[7][9]. When activated, Rap1 regulates diverse cellular functions, particularly affecting cell adhesion (both integrin- and cadherin-mediated), cell polarity, migration, and cytoskeletal dynamics[1][3][6]. Rap1 signaling is crucial in vascular biology, immunology, and the pathogenesis of cancer and diabetes, where its dysregulation is linked to processes such as tumor metastasis, pancreatic β-cell function, and vascular barrier stability[1][2][3][5][8]. Because "Rap1 signaling pathway" describes a set of interactions rather than a single molecule, it is not, on its own, a classic molecular target; however, its components are emerging as therapeutic intervention points in oncology, metabolic, and vascular diseases[1][2][5][8].

Other names

Rap1 pathwayRap1 GTPase signalingRas-proximate-1 pathway

Inhibitors targeting Rap1 or its upstream activators (e.g., GEFs) can block its activation, thereby inhibiting cell migration, invasion, and proliferation in cancers Agonists/activators promote beneficial Rap1 effects, such as enhancing β-cell proliferation and insulin secretion in diabetes models